Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07075159 · ClinicalTrials.gov registry record · NA

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

A NA study of Wound Healing and Mohs Micrographic Surgery, sponsored by Janice Hernandez, MD.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07075159 is a NA study of Wound Healing and Mohs Micrographic Surgery that is actively recruiting participants, run by Janice Hernandez, MD. The registered enrollment target is 20 participants, below the 56-participant average among 11 other Wound Healing trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07075159, a NA study of Wound Healing and Mohs Micrographic Surgery, is actively recruiting participants, sponsored by Janice Hernandez, MD.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.

Interventions

  • DEVICE Hydrocolloid Wound Dressing

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-02-28
Est. Completion 2026-09-01
Phase NA

Sponsor

Janice Hernandez, MD

1 total trials

What the Registry Record Tells You About NCT07075159

The ClinicalTrials.gov registry entry for NCT07075159 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 11 other Wound Healing trials with a reported enrollment target (64% lower). The listed sponsor is Janice Hernandez, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Wound Healing appearing as the primary indexed condition, and to 1 intervention - of which Hydrocolloid Wound Dressing is the first listed.

NCT07075159 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT07075159 about?

NCT07075159 is a clinical study titled "Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing". This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointm...

What is the current status of trial NCT07075159?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-28. Estimated completion is 2026-09-01.

What conditions does trial NCT07075159 study?

This clinical trial studies the following conditions: Wound Healing, Mohs Micrographic Surgery, Oculofacial Reconstruction.

What interventions are being tested in trial NCT07075159?

The interventions under investigation include: Hydrocolloid Wound Dressing (DEVICE).

Who is sponsoring clinical trial NCT07075159?

This trial is sponsored by Janice Hernandez, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07075159 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wound Healing

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.